CN1170408A - 2-氨基甲酰基-1,4,5,6-四氢吡嗪 - Google Patents

2-氨基甲酰基-1,4,5,6-四氢吡嗪 Download PDF

Info

Publication number
CN1170408A
CN1170408A CN95196942A CN95196942A CN1170408A CN 1170408 A CN1170408 A CN 1170408A CN 95196942 A CN95196942 A CN 95196942A CN 95196942 A CN95196942 A CN 95196942A CN 1170408 A CN1170408 A CN 1170408A
Authority
CN
China
Prior art keywords
acid
formula
formamyl
bronsted acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95196942A
Other languages
English (en)
Chinese (zh)
Inventor
C·卡恩德兹亚
M·亨宁格森
S·多伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CN1170408A publication Critical patent/CN1170408A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN95196942A 1994-12-22 1995-08-01 2-氨基甲酰基-1,4,5,6-四氢吡嗪 Pending CN1170408A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4446025A DE4446025A1 (de) 1994-12-22 1994-12-22 2-Caroxamido-1,4,5,6-tetrahydropyrazine
DEP4446025.2 1994-12-22

Publications (1)

Publication Number Publication Date
CN1170408A true CN1170408A (zh) 1998-01-14

Family

ID=6536749

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95196942A Pending CN1170408A (zh) 1994-12-22 1995-08-01 2-氨基甲酰基-1,4,5,6-四氢吡嗪

Country Status (5)

Country Link
EP (1) EP0799211A1 (de)
JP (1) JPH10510818A (de)
CN (1) CN1170408A (de)
DE (1) DE4446025A1 (de)
WO (1) WO1996019460A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4538296A (en) * 1995-01-23 1996-08-14 Lonza A.G. Process for the production of 1,4,5,6-tetrahydropyrazine-2-carboxylic acid amides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
JP3547136B2 (ja) * 1993-07-16 2004-07-28 メルク エンド カンパニー インコーポレーテッド Hivプロテアーゼ阻害剤の製造方法
US5734055A (en) * 1993-11-22 1998-03-31 Koei Chemical Co. Ltd. Process for preparing N-tert-butyl-2-pyrazinecarboxamide and N-tert-butyl-2-piperazinecarboxamide

Also Published As

Publication number Publication date
JPH10510818A (ja) 1998-10-20
WO1996019460A1 (de) 1996-06-27
DE4446025A1 (de) 1996-06-27
EP0799211A1 (de) 1997-10-08

Similar Documents

Publication Publication Date Title
EP2319621A2 (de) Basenstabile ionische Flüssigkeiten
KR20120099299A (ko) Romp과 pcm반응에 대해서 선택적인 고활성 복분해 촉매제
CN101306383B (zh) 杂多酸负载的手性有机小分子催化剂及其制备方法与应用
CN102458659A (zh) 不对称氢化催化剂
CN107805205A (zh) 一种(r)‑3‑氨基丁醇的制备方法
CN112916042B (zh) 基于四甲基螺二氢茚骨架的手性季铵盐相转移催化剂及制备方法
US4652657A (en) Chiral rhodium-diphosphine complexes
Cunningham et al. On the use of mixtures of organotin species for catalytic enantioselective ketone allylation—A detective story
CN1966476A (zh) 铁催化的烯丙基烷基化
EP4159719A1 (de) Verfahren zur herstellung von (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)methylpropionat-disäuresalz
Gong et al. BF3-Promoted aromatic substitution of N-alkyl α-trifluoromethylated imine: facile synthesis of 1-aryl-2, 2, 2-trifluoroethylamines
JPH0667947B2 (ja) ルテニウム−ホスフイン錯体
CN1170408A (zh) 2-氨基甲酰基-1,4,5,6-四氢吡嗪
CN103648645B (zh) 用于制备钯(i) 三叔丁基膦溴化物二聚体的方法及其在异构化反应中的使用方法
CN101003456B (zh) 制备β-γ不饱和酯的方法
CN107021982A (zh) 三取代氧膦化合物或三取代二氧膦化合物的合成方法
CN113651773A (zh) 一种氧化甲基吗啉的合成和提纯方法
EP4163271A1 (de) Verfahren zur herstellung von methyl-(s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenylpropionat und salz daraus
CN115650824B (zh) 手性二醇及其制备方法、制得的催化剂及制备方法和应用
KR100928656B1 (ko) 1,2,4-부탄트리올의 제조 방법
CN105294479A (zh) 一种3r-氨基取代丁酰胺衍生物的制备方法
JP2001026580A (ja) 光学活性1−アリール−1,2,3,4−テトラヒドロイソキノリン類の製造法
US7151070B2 (en) Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols
JP2981621B2 (ja) ビフェニルビスホスフィン錯体
CN1176054C (zh) 1,3-丙二醇中羰基物质的脱除方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication